EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies

Tingting Hu iD, Jifa Zhang iD, Jiaxing Wang, Leihao Sha, Yilin Xia, Tyler C Ortyl, Xiaohe Tian iD, Lei Chen

Journal of Medicinal Chemistry · 13.04.2023 · 66 (7) · 4434-4467

DOI: 10.1021/acs.jmedchem.2c01975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 04.04.2023. Verfasst von Tingting Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Joint Research Institution of Altitude Health, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Resea…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 320 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China, Key Research and Development Plan of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a common disease of the nervous system characterized by transient brain dysfunction caused by an abnormal electrical discharge from the brain neurons. The pathogenesis of epilepsy is complex and remains elusive. Nowadays, drug therapy is the mainstay method for the treatment of epilepsy. More than 30 antiseizure drugs (ASDs) were approved for clinical use. Unfortunately, about 30% of patients still display pharmacoresistance against ASDs. The long-term use of ASDs may cause adverse effects, raise tolerability concerns, bring unexpected drug interactions, generate withdrawal symptoms, and increase the economic burden. Thus, the research uncovering more effective ASDs that are safe is still a difficult and urgent task. In this Perspective, we describe the pathogenesis, clinical trials, and drug therapy progress of epilepsy, focusing on summarizing the current situation of small-molecule drug candidates progressing in epilepsy therapy, which provides future directions for the development of more promising ASDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyHumansSubstance Withdrawal Syndrome

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, Joint Research Institution of Altitude Health, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Ch…
  • Precision Medicine Key Laboratory of Sichuan Province & Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, 38163 Tennessee, United States.

ORCID-Profile: Tingting Hu, Jifa Zhang, Xiaohe Tian

Förderung

  • Natural Science Foundation of Sichuan Province
  • National Natural Science Foundation of China
  • Key Research and Development Plan of Sichuan Province

Zitieren

APA

Hu, T., Zhang, J., Wang, J., Sha, L., Xia, Y., Ortyl, T. C., Tian, X., & Chen, L. (2023). Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies. Journal of Medicinal Chemistry, 66(7), 4434-4467. https://doi.org/10.1021/acs.jmedchem.2c01975

Vancouver

Hu T, Zhang J, Wang J, Sha L, Xia Y, Ortyl TC, et al. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies. Journal of Medicinal Chemistry. 2023;66(7):4434-4467. doi:10.1021/acs.jmedchem.2c01975

BibTeX
@article{Hu2023,
  author = {Hu, Tingting and Zhang, Jifa and Wang, Jiaxing and Sha, Leihao and Xia, Yilin and Ortyl, Tyler C and Tian, Xiaohe and Chen, Lei},
  title = {Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {7},
  pages = {4434--4467},
  doi = {10.1021/acs.jmedchem.2c01975}
}
Kostenlos starten →